95252 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#902PYRIMIDINEDIONE COMPOUNDS
#903N-SUBSTITUTED INDOLE DERIVATIVES
#904AXL KINASE INHIBITORS AND USE OF THE SAME
#905CHEMICAL COMPOUNDS
#906TYK-2 INHIBITOR
#907INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE
#908INDOLE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
#909Antimicrobial Compounds and Methods
#910NOVEL PHTHALAZINE DERIVATIVE HAVING ECTONUCLOEOTIDE PYROPHOSPHATASE/PHOSPHODIESTE RASE INHIBITORY ACTIVITY, AND USE THEREOF
#911IMMUNOMODULATOR
#912INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION
#913Inhibitors of protein arginine deiminases
#914Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
#915ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
#916N-HETEROARYLALKYL-2-(HETEROCYCLYL AND HETEROCYCLYLMETHYL) ACETAMIDE DERIVATIVES AS SSTR4 AGONISTS
#917COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
#918AMIDE-DISUBSTITUTED PYRIDINE OR PYRIDAZINE COMPOUNDS
#919PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS
#920Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
#921PYRIMIDINE-2,4-DIAMINE COMPOUND AND PREPAREATION METHOD AND APPLICATION THEREOF
#922Host-targeted pan-respiratory antiviral small molecule therapeutics
#923Indoline compounds for inhibiting KIF18A
#924BENZIMIDAZOLONE-BASED CINNAMAMIDE DERIVATIVE AS TRPV1 ANTAGONIST AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF PAIN CONTAINING SAME AS ACTIVE INGREDIENT
#925SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
#926MASP-2 inhibitors and methods of use
#927Sulphonyl urea derivatives as NLRP3 inflammasome modulators
#928Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
#929LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS
#930N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
#931NOVEL COMPOUND, PREPARATION METHOD THEREOF, AND USE THEREOF
#932SUBSTITUTED ARYL COMPOUND
#933TETRACYCLIC COMPOUND
#934SUBSTITUTED BENZENECARBOXAMIDES AS IL-17A MODULATORS
#935AZIRIDINE FUNCTIONAL COMPOUND
#936COMBINATION THERAPY FOR TREATING MPS1
#937Inhibitors of platelet function and methods for use of the same
#938PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND
#939PYRAZOLE CARBOXYLATE ESTER COMPOUND AND USE THEREOF
#9406-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING DISEASES AND CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY
#941Multi-aziridine compound
#942Myc-Max inhibitor compound therapeutics for cancer treatment, methods and uses associated therewith
#943Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same
#944Compositions and methods for treating and preventing neurodegenerative disorders
#945PYRIMIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USES
#946Small Molecule Activators of Parkin Enzyme Function
#947COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#948MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#949Multi-aziridine compound
#950G9a INHIBITOR
#951Hydantoin containing deoxyuridine triphosphatase inhibitors
#952Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
#953SMALL MOLECULE STING ANTAGONISTS
#954Methods and compositions of 4-substituted benzoylpiperazine-1-substituted carbonyls as β-catenin/B-cell lymphoma 9 inhibitors
#955COATING COMPOSITION
#956OX2R compounds
#957BTK INHIBITORS
#958MONOACYLGLYCEROL LIPASE INHIBITORS
#959COMPOUNDS AND USES THEREOF
#960RORgT INHIBITOR, PREPARATION METHOD THEREOF AND USE THEREOF
#961Nitrile-Containing Antiviral Compounds
#962Cardiac sarcomere inhibitors
#963A HISTONE DEACETYLASE INHIBITOR HAVING A NITROGEN-CONTAINING AROMATIC HETEROCYCLYL GROUP
#964Method and apparatus for sorting heterogeneous material
#965LIPOXYGENASE INHIBITORS
#966NITROGEN CONTAINING HETEROCYCLES AS CDK12 INHIBITORS
#967Solid state forms of Belumosudil and Belumosudil salts
#968Small molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and uses thereof
#969THERAPEUTIC COMPOUNDS AND USES THEREOF
#970COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
#971Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
#972Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for Their Preparation and Therapeutic Uses Thereof
#973Pyrazole derivatives with anticancer activity
#974Amide compounds and method for making and using
#975Complement Modulators and Related Methods
#976HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#977METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF
#978RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
#979THIOSEMICARBAZATES AND USES THEREOF
#980STABILIZATION OF MHC COMPLEXES
#981Methods and compositions useful in treating cancer and reducing Wnt mediated effects in a cell
#982Substituted bicyclic compounds as farnesoid X receptor modulators
#983SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY
#984PYRIDAZINONE OR PYRIDAZINE COMPOUND AND DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF
#985HEPATITIS B CAPSID ASSEMBLY MODULATORS
#986ARYL-N-ARYL DERIVATIVES FOR TREATING A RNA VIRUS INFECTION
#987Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof
#988JNK INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
#989SMYD Inhibitors
#990DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS
#991MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
#992Human plasma kallikrein inhibitors
#993DRG-MDM2-6 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
#994METHODS FOR CELL IMAGING
#9951,2-diaminobenzimidazole derivative
#996MULTI-AZIRIDINE COMPOUND
#997AZETIDINE SULFONAMIDE COMPOUND
#998WATERBORNE CROSSLINKER COMPOSITION
#999COMPOUNDS, COMPOSITIONS, METHODS FOR TREATING DISEASES AND NERVE DAMAGE, AND METHODS FOR PREPARING COMPOUNDS
#10002,4-DIAMINO-PYRIMIDINE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS
#1001Human plasma kallikrein inhibitors
#1002A NOVEL MAO-B INHIBITOR DRG-MAOB-1 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
#1003Anti-viral compounds
#1004AMINO QUINAZOLINE DERIVATIVES AS P2X3 INHIBITORS
#1005COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#1006Bifunctional chimeric heterocyclic compounds for targeted degradation of androgen receptors and use thereof
#1007AMINOPYRIMIDINYLAMINOBENZONITRILE DERIVATIVES AS NEK2 INHIBITORS
#10081,2,4-TRIAZINE-3,5-DIONE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#1009GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
#1010A NOVEL SELECTIVE MAO-B INHIBITOR DRG-MAOB-2 FOR USE IN TREATMENT OF NEURODEGENERATIVE DISEASES
#1011GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
#1012CBL-B MODULATORS AND USES THEREOF
#1013ACSS2 INHIBITORS AND METHODS OF USE THEREOF
#1014INHIBITORS OF ANOCTAMIN 6 PROTEIN AND USES THEREOF
#1015GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE
#1016INDAZOLES AND AZAINDAZOLES AS LRRK2 INHIBITORS
#1017MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
#1018Substituted indoles and methods of use thereof
#1019Cycloalkane-1,3-diamine derivative
#1020DRG-MDM2-4 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR
#1021AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE
#1022TWO-COMPONENT COATING SYSTEM
#1023NURR1 RECEPTOR MODULATORS
#1024HEPATITIS B CAPSID ASSEMBLY MODULATORS
#1025NEW FYN AND VEGFR2 KINASE INHIBITORS
#1026Antibacterial compounds
#1027Diacylglycerol kinase modulating compounds
#1028HETEROCYCLIC RIP1 KINASE INHIBITORS
#1029Human plasma kallikrein inhibitors
#1030Anti-malarial agents
#1031MONOMER AND MULTIMERIC ANTI-HBV AGENTS
#1032MTA-Cooperative PRMT5 Inhibitors
#1033MULTI-AZIRIDINE COMPOUND
#1034PD-L1 ANTAGONIST COMPOUND
#1035IL-17 ligands and uses thereof
#1036TASPASE1 INHIBITORS AND USES THEREOF
#1037Compounds
#1038Inhibitors of NLRP3 inflammasome
#1039NOVEL PHENOL COMPOUND OR SALT THEREOF
#1040DEUCRAVACITINIB CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF
#1041COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#1042TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES
#1043Hepatitis b core protein modulators
#1044Certain chemical entities, compositions, and methods
#1045Compounds, Compositions and Methods
#1046MATRIPTASE 2 INHIBITORS AND USES THEREOF
#1047Quinazoline Compounds
#1048SMALL MOLECULE MODULATORS OF SIGMA-1 AND SIGMA-2 RECEPTORS AND USES THEREOF
#1049METHODS AND MATERIALS FOR INHIBITING NF-kB ACTIVITY
#1050AROMATIC SULPHONAMIDES DERIVATIVES THAT INHIBITS PDI A3, THEIR SYNTHESIS AND USE
#1051Bicyclic compounds as androgen receptor modulators
#1052Substituted indole Mcl-1 inhibitors
#1053BMS-986165 CRYSTAL FORM, PREPARATION METHOD THEREFOR AND USE THEREOF
#1054Capsid inhibitors for the treatment of HIV
#1055Alkene-containing amide compound and application thereof
#1056Protease Inhibitors for Treatment of Coronavirus Infections
#1057Quaternary indazole glucocorticoid receptor antagonists
#1058Methods and compositions for targeting PD-L1
#1059CYCLOALKANE-1,3-DIAMINE DERIVATIVE
#1060COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
#1061CHIRAL GUANIDINES, SALTS THEREOF, METHODS OF MAKING CHIRAL GUANIDINES AND SALTS THEREOF, AND USES OF CHIRAL GUANIDINES AND SALTS THEREOF IN THE PREPARATION OF ENANTIOMERICALLY PURE AMINO ACIDS
#1062SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS
#1063MrgprX2 Antagonists and Uses Thereof
#1064NOVEL PYRIDINYLTRIAZINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING CANCER COMPRISING SAME
#1065FXIA INHIBITORS AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
#1066HIV inhibitor compounds
#1067TRPV4 RECEPTOR LIGANDS
#1068ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#1069Protease inhibitors as antivirals
#1070NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF
#1071Checkpoint kinase 1 (CHK1) inhibitors and uses thereof
#1072TRIARYLAMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF
#1073Substituted pyrazole amides
#1074INHIBITORS OF HIF-2ALPHA
#1075Heteroaryl inhibitors of PDE4
#1076Protease inhibitors for treatment of coronavirus infections
#1077Substituted pyridazines as TYK2 inhibitors
#1078N-(HETEROARYL) QUINAZOLIN-2-AMINE DERIVATIVES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
#1079WDR5-MYC INHIBITORS
#1080Modulators of Rho-associated protein kinase
#1081Piperidinyl-3-(aryloxy)propanamides and propanoates
#1082GLP-1R MODULATING COMPOUNDS
#1083Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors
#1084COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#10851,2,4-triazine-4-amine derivatives
#1086SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS
#1087Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
#1088HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS
#1089Quinazolinones as PARP14 inhibitors
#10901-AMINOSULFONYL-2-CARBOXYPYRROLE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS
#1091PHTHALAZINONE DERIVATIVES
#1092INHIBITORS OF APOL1 AND METHODS OF USING SAME
#1093Antibacterial compounds
#1094SUBSTITUTED TRICYCLIC COMPOUNDS
#1095HEPATITIS B ANTIVIRAL AGENTS
#1096COMPOUNDS FOR THE TREATMENT OF HIV
#1097Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B
#1098Inhibitors of APOL1 and methods of using same
#10994,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseases
#1100A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP
#1101INDOLINONE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS
#11023-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF
#1103Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
#1104BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF
#11057-PYRIMIDINE-2-YL-OXY-INDAZOLE DERIVATIVES AND THEIR USE AS HERBICIDES
#1106COMPOUNDS AND USES THEREOF
#1107SULFONAMIDE DERIVATIVES AS CTPS1 INHIBITORS
#1108Fused ring compounds
#1109Glycosidase inhibitors
#1110Modulators of eukaryotic initiation factor 2B, compositions and methods
#1111Novel compounds and their use in therapy
#1112CDGSH iron sulfur domain 2 activators and use thereof
#1113Modulators of ATP-binding cassette transporters
#1114Small Molecule Compound
#1115AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS
#1116BENZODIAZEPINE DERIVATIVES FOR TREATING A RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION
#1117CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS WITH ENHANCED EFFICACY
#1118COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG AND A CO-POLYAMINO ACID
#1119ORGANIC ELECTROLUMINESCENT DEVICE
#1120BCL-2 inhibitors
#1121COMPOUNDS FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
#1122INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#1123Method and System for Synthesising Compounds
#1124TRIAZACYCLODODECANSULFONAMIDE (TCD)-BASED PROTEIN SECRETION INHIBITORS
#1125SMALL MOLECULE PROSTAGLADIN TRANSPORT INHIBITORS
#1126Hydantoin containing deoxyuridine triphosphatase inhibitors
#1127S1P3 Antagonists
#1128HERBICIDAL COMPOUNDS
#1129COMPOUNDS AS MODULATORS OF TLR2 SIGNALING
#1130Pyrimidine compound as JAK kinase inhibitor
#1131NOVEL HETEROCYCLIC COMPOUNDS
#1132TREATMENT OF GVHD
#1133BAX INHIBITORS AND USES THEREOF
#1134INHIBITORS OF ERYTHROCYTE BAND 3 TYROSINE PHOSPHORYLATION AND USES THEREOF
#1135Phenyl Amino Pyrimidine Compounds and Uses Thereof
#1136(AZA)INDAZOLYL-ARYL SULFONAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
#1137COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
#11381,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
#1139UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#1140ANDROGEN RECEPTOR MODULATORS AND METHODS FOR THEIR USE
#1141PHARMACEUTICAL COMPOUNDS
#1142AXL INHIBITOR FORMULATIONS
#1143INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#1144P2X4 receptor antagonist
#1145SUBSTITUTED BENZIMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#1146CHK1/2 INHIBITORS FOR USE IN THE TREATMENT OF NEUROBLASTOMAS AND/OR SOFT TISSUE SARCOMAS
#1147COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS
#1148Heterocyclic compounds and uses thereof
#1149COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS
#1150RESMETIROM CRYSTAL, PREPARATION METHOD FOR SAME, AND USES THEREOF
#1151Cycloolefin substituted heteroaromatic compounds and their use
#1152Theramutein modulators
#1153T-TYPE CALCIUM CHANNEL BLOCKER
#1154Glucose uptake inhibitors
#1155Beta-amino acid derivative, kinase inhibitor and pharmaceutical composition containing the same, and method for performing an in vivo related application that benefits from the inhibition of a kinase
#1156Small molecules that sensitize HIV-1 infected cells to antibody dependent cellular cytotoxicity
#1157Theramutein modulators
#1158INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#11593,5-DISUBSTITUTED PYRAZOLE COMPOUNDS AS KINASE INHIBITORS AND USES THEREOF
#1160AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES
#11615-membered and bicyclic heterocyclic amides as inhibitors of ROCK
#1162Kv11.1-3.1 INHIBITING METHODS AND COMPOSITIONS
#1163Aryl-n-aryl derivatives for treating a RNA virus infection
#1164ISOINDOLINE DERIVATIVES
#1165Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
#1166ANTIVIRAL COMPOUNDS
#1167Substituted quinazolines for inhibiting kinase activity
#11687-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
#1169Benzoimidazole Derivatives As Anticancer Agents
#1170THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
#1171N-(1H-IMIDAZOL-2-YL)BENZAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME AS ACTIVE INGREDIENT
#1172Bicyclic lactams and methods of use thereof
#11732-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE
#1174INHIBITORS OF SARM1
#1175Inhibitors of APOL1 and methods of using same
#1176REVERSIBLE FIXING REAGENTS AND METHODS OF USE THEREOF
#1177Imidazole-containing inhibitors of ALK2 kinase
#1178N2-phenylpyrimidine-2,4-diamine compounds, and preparation methods and methods of use thereof
#1179SULFONAMIDE COMPOUNDS AS CARDIAC SARCOMERE ACTIVATORS
#1180Halogen-substituted phenylate compound and applications thereof
#1181CRYSTALLINE FORMS OF A JAK2 INHIBITOR
#1182Biaryl inhibitors of Bruton's tyrosine kinase
#1183ONIUM SALT OF NITROGEN-CONTAINING HETEROARYL COMPOUND AND PEST CONTROL AGENT
#1184AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, SALTS THEREOF, AND METHODS OF SYNTHESIS THEREOF
#1185Inhibitors of LRRK2 kinase
#1186INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF
#1187DICARBOXYLIC ACID BISAMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS FOR PRODUCING DICARBOXYLIC ACID BISAMIDE DERIVATIVES
#1188CANCER TREATMENTS TARGETING CANCER STEM CELLS
#1189QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS
#1190INHIBITORS OF CBL-B AND METHODS OF USE THEREOF
#1191Inhibitors of NLRP3 inflammasome
#1192SARS-3CL PROTEASE INHIBITORS
#1193Combination pharmaceutical agents as RSV inhibitors
#1194Methods and compounds for restoring mutant p53 function
#1195ALK-5 inhibitors and uses thereof
#1196Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
#1197APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
#1198MACROMOLECULE-SUPPORTED AMINOBENZAZEPINE COMPOUNDS
#1199HYDANTOIN DERIVATIVE
#1200COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS